Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 5, 2013, Pages

  Dal Bello Haas, Vanina ^a   Florence, Julaine M ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; AEROBIC EXERCISE; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE; CLINICAL OUTCOME; EMOTIONALITY; ENDURANCE TRAINING; EXERCISE INTENSITY; FUNCTIONAL STATUS; HEALTH PROGRAM; HEALTH STATUS; HUMAN; KINESIOTHERAPY; MENTAL HEALTH; MOTOR NEURON DISEASE; MUSCLE CRAMP; MUSCLE FATIGUE; MUSCLE STRENGTH; MUSCLE TRAINING; MYOSITIS; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PHYSICAL PERFORMANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REHABILITATION CARE; RESISTANCE TRAINING; REVIEW; SCORING SYSTEM; SHORT FORM 36; SOCIAL STATUS; SYSTEMATIC REVIEW; ENDURANCE; EXERCISE TOLERANCE; META ANALYSIS; METHODOLOGY; MUSCLE WEAKNESS; PSYCHOLOGICAL ASPECT; PROCEDURES; PSYCHOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; PHYSICAL ENDURANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891372363     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005229.pub3     Document Type: Review

References (54)

1. Dal Bello-Haas VP, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, et al.A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 2007;68(23):2003-7. [PUBMED: 17548549].
2. Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. Journal of Neurological Sciences 2001;191(1-2):133-7. [PUBMED: 11677004].
3. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Archives of Physical Medicine & Rehabilitation 1993;74(7):711-5.
4. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL, et al.Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986;36(7):937-41.
5. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Annals of Neurology 1987;22(3):328-33.
6. Bennett RL, Knowlton GC. Overwork weakness in partially denervated skeletal muscle. Clinical Orthopaedics and Related Research 1958;12:22-9.
7. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Medical Care 1981;19(8):787-805.
8. Bohannon RW. Results of resistance exercise on a patient with amyotrophic lateral sclerosis. Physical Therapy 1983;63(6):965-8.
9. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1(5):293-9.
10. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences 1999;169(1-2):13-21.
11. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale: Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Archives of Neurology 1996;53(2):141-7.
12. Coble NO, Maloney FP. Interdisciplinary rehabilitation of multiple sclerosis and neuromuscular disorders. In: Maloney FP, Burks JS, Ringel SP editor(s). Effects of Exercise in Neuromuscular Disease. New York: JB Lippincott, 1985:228-38.
13. Deforges S, Branchu J, Biondi O, Grondard C, Pariset C, Lécolle S, et al.Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. Journal of Physiology 2009;587(Pt 14):3561-751.
14. Einarsson G. Muscle conditioning in late poliomyelitis. Archives of Physical Medicine and Rehabilitation 1991;72(1):11-4.
15. Florence JM, Hagberg JM. Effects of training on the exercise response of neuromuscular disease patients. Medicine and Science in Sports and Exercise 1984;16(5):460-5.
16. Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis: A study of its presentation and prognosis. Journal of Neurology 1985;232(5):295-300.
17. Hamida MB, Hentati F. Juvenile amyotrophic lateral sclerosis. In: Brown R Jr, Meininger V, Swash M editor(s). Amyotrophic Lateral Sclerosis. London: Martin Dunitz Ltd, 2000:59-79.
18. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118(Pt 3):707-19.
19. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org.
20. Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N. Amyotrophic Lateral Sclerosis Severity Scale. Neuroepidemiology 1989;8(3):142-50.
21. Jenkinson C, Fitzpatrick R, Brennan M, Bromberg M, Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 1999;1(1):33-40.
22. Jenkinson C, Fitzpatrick R, Brennan C, Bromberg M, Swash M. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. Journal of Neurology 1999;246(Suppl 3):16-21.
23. Johnson EW, Braddom R. Overwork weakness in facioscapulohumeral muscular dystrophy. Archives of Physical Medicine and Rehabilitation 1971;52(7):333-6.
24. Kaspar BK, Frost LM, Christian L, Umapathi P, Gafe FH. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Annals of Neurology 2005;57(5):649-55.
25. Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Archives of Physical Medicine and Rehabilitation 1994;75(5):560-3.
26. Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Annals of Neurology 2003;53(6):804-7.
27. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology 1989;46(10):1121-23.
28. Kurtzke JF. Risk factors in amyotrophic lateral sclerosis. Advances in Neurology 1991;56:245-70.
29. Lindeman E, Leffers P, Spaans F, Drukker J, Reuben J, Kerckhoffs M. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Archives of Physical Medicine and Rehabilitation 1995;76(7):612-20.
30. Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky M. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle & Nerve 2004;29(5):656-62.
31. McCartney N, Moroz D, Garner SH, McComas AJ. The effects of strength training in patients with selected neuromuscular disorders. Medicine and Science in Sports and Exercise 1988;20(4):362-8.
32. Milner-Brown HS, Miller RG. Muscle strengthening through high resistance weight training in patients with neuromuscular disorders. Archives of Physical Medicine and Rehabilitation 1988;69(1):14-9.
33. Mitsumoto H, Chad DA, Pioro EK. Clinical features: Signs and symptoms. In: Mitsumoto H, Chad DA, Pioro EK editor(s). Amyotrophic Lateral Sclerosis. Philadelphia: F.A. Davis Company, 1998:47-64.
34. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 1986;36(4):511-7.
35. Norris FH Jr, Calanchini PR, Fallat RF, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974;24(8):721-8.
36. Norris F, Shepherd R, Denys E, Mukai E, Elias L, Holden D. Onset, natural history and outcome in idiopathic adult motor neuron disease. Journal of the Neurological Sciences 1993;118(1):48-55.
37. Pinto AC, Alves M, Nogueira A, Evangelista T, Carvalho J, Coelho A, et al.Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?. Journal of the Neurological Sciences 1999;169(1-2):69-75.
38. Pradas J, Finison L, Andres PL, Thornell B, Hollander D, Munsat TL. The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials. Neurology 1993;43(4):751-5.
39. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
40. Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al.The natural history of amyotrophic lateral sclerosis. Neurology 1993;43(7):1316-22.
41. Rowland LP. Diverse forms of motor neuron disease. Advances in Neurology 1982;36:1-13.
42. Sanjak M, Reddan W, Brooks BR. Role of muscular exercise in amyotrophic lateral sclerosis. Neurology Clinics 1987;5(2):251-68, vi.
43. Schwab R, England A. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham J, Donaldson I editor(s). Third Symposium on Parkinson's Disease. Edinburgh: Livingstone, 1969.
44. Sinaki M, Mulder DW. Rehabilitation techniques for patients with amyotrophic lateral sclerosis. Mayo Clinic Proceedings 1978;53(3):173-8.
45. Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs R. Physical activity, trauma, and ALS: a case-control study. Acta Neurologica Scandinavica 1996;94(1):45-50.
46. Strong MJ, Hudson AJ, Alvord WG. Familial amyotrophic lateral sclerosis, 1850-1989: A statistical analysis of the world literature. Canadian Journal of Neurological Sciences 1991;18(1):45-58.
47. Swash M, Desai J. Motor neuron disease: classification and nomenclature. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1(2):105-12.
48. Swash M. Clinical features and diagnosis of amyotrophic lateral sclerosis. In: Brown R Jr, Meininger V, Swash M editor(s). Amyotrophic Lateral Sclerosis. London: Martin Dunitz Ltd, 2000:3-30.
49. Voet NBM, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BGM, Geurts ACH. Strength training and aerobic exercise training for muscle disease. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD003907.pub3].
50. Veldink JH, Bar PR, Joosten EAJ, Otten M, Wokke JHJ, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscular Disease 2003;13(9):737-43.
51. Vignos PJ Jr. Physical models of rehabilitation in neuromuscular disease. Muscle & Nerve 1983;6(5):323-38.
52. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: Health Institute, New England Medical Center, 1993.
53. DalBello-Haas V, Florence J, Krivickas L. Therapeutic exercise for people with amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005229].
54. Dal Bello-Haas V, Florence JM, Krivickas LS. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005229.pub2].